Internal Medicine, Hematology & Oncology · Owosso, MI
NPI
1275625147
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
721 N Shiawassee St Ste 101
Owosso, MI, 48867
Phone (989) 729-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
880 services
Medicare patients, 2024
286
Average age 74
Drug cost, 2024
$5.2M
1,890 prescriptions
Company payments, 2025
$1,187
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald H Kawauchi was code 99214 (office e&m - established), 592 times for 211 patients. In total Ronald H Kawauchi billed 880 services in 13 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 592 | 211 | $67.88 | $40K |
| 99232 Hospital E&M - Subsequent | Facility | 112 | 53 | $59.40 | $6,652 |
| 99222 Hospital E&M - Initial | Facility | 38 | 34 | $100.07 | $3,803 |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 15 | $37.13 | $1,077 |
| 99204 Office E&M - New | Facility | 23 | 23 | $96.97 | $2,230 |
| 99203 Office E&M - New | Facility | 23 | 23 | $50.60 | $1,164 |
| 99213 Office E&M - Established | Facility | 22 | 21 | $50.51 | $1,111 |
By year: 2022 $44K for 746 services; 2023 $58K for 827 services; 2024 $60K for 880 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald H Kawauchi prescribed most often to Medicare patients was Eliquis (Apixaban), with 161 prescriptions and refills. In total Ronald H Kawauchi wrote 1,890 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 161 | 225 | 28 | $128K |
| Letrozole Generic | 158 | 463 | 51 | $6,764 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 71 | 71 | 31 | $1,032 |
| Potassium Chloride Generic | 71 | 87 | 26 | $805 |
| Ondansetron Hcl Generic | 69 | 85 | 44 | $1,102 |
| Furosemide Generic | 60 | 69 | 24 | $165 |
| Prednisone Generic | 59 | 71 | 27 | $399 |
| Olanzapine Generic | 54 | 61 | 20 | $492 |
| Warfarin Sodium Generic | 51 | 146 | 13 | $579 |
| Allopurinol Generic | 48 | 86 | 18 | $540 |
| Anastrozole Generic | 45 | 123 | 14 | $953 |
| Acyclovir Generic | 45 | 57 | 11 | $610 |
| Xarelto Rivaroxaban | 43 | 85 | 12 | $44K |
| Imbruvica Ibrutinib | 40 | 40 | Under 11 | $593K |
| Xtandi Enzalutamide | 40 | 40 | Under 11 | $459K |
Brand drugs: - claims; generic drugs: 1,338 claims; opioid claims: 188.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald H Kawauchi $1,187 ($1,187 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novartis Pharmaceuticals Corporation with $200.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 16 | $200 |
| Aveo Pharmaceuticals, Inc. | 6 | $193 |
| Pfizer Inc. PFE | 3 | $62.12 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $52.95 |
| Array Biopharma Inc PFE | 2 | $49.77 |
| BeOne Medicines USA, Inc. ONC | 2 | $46 |
| Merck Sharp & Dohme LLC MRK | 2 | $44.63 |
| Gilead Sciences, Inc. GILD | 2 | $43.6 |
| Abbvie Inc. ABBV | 2 | $43.45 |
| Astellas Pharma US Inc 4503.T | 2 | $43.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.